معرفی
Ben Boyd is an Affiliate Professor in the Department of Pharmacy at the University of Copenhagen, where he leads research in the Drug Delivery and Biophysics of Biopharmaceuticals group. His work focuses on developing innovative drug delivery systems with particular expertise in lipid-based formulations and nanocarrier technologies. As a Novo Nordisk Foundation Laureate Research Fellow, he has established himself as a leading researcher in pharmaceutical sciences with significant contributions to understanding drug behavior in biological environments.
Dr. Boyd's research interests span multiple dimensions of modern drug delivery science. His work particularly emphasizes lipid-based drug delivery systems, nanocarrier development, and the biophysics of biopharmaceuticals. He investigates how drugs interact with biological systems, particularly in gastrointestinal conditions, and develops analytical methods to characterize complex drug formulations. His research has important implications for improving the bioavailability of poorly water-soluble drugs through innovative delivery approaches.
Analysis of his recent publications reveals a strong focus on advanced analytical techniques, particularly Raman spectroscopy for pharmaceutical characterization, and novel approaches to drug delivery including metabolic glycan labeling and asymmetric nanocapsule development. His work bridges fundamental science with practical applications in drug formulation and delivery.
- Novo Nordisk Foundation Laureate Research Fellow
Dr. Boyd maintains active research collaborations across multiple institutions, with particular strength in nanomedicine and pharmaceutical analysis. His laboratory employs cutting-edge techniques to study drug behavior in complex biological environments, with applications ranging from pediatric formulations to advanced cancer therapeutics. Current research directions include developing non-invasive analytical methods for packaged pharmaceuticals and exploring the potential of human milk components to enhance drug bioavailability.
